Enovis Corporation will host a Q2 2025 earnings call on August 7, 2025, with a live webcast available.
Quiver AI Summary
Enovis Corporation announced it will host an investor conference call and live webcast to discuss its second quarter 2025 financial results on August 7, 2025, at 8:30 a.m. Eastern Time, following an earnings press release earlier that morning. The event can be accessed through the "Investors" section of Enovis' website. Investors can participate in the call by dialing (833) 685-0901, and a replay will be available on the website later that day. Enovis is a medical technology growth company focused on delivering clinically differentiated solutions to improve patient outcomes and enhance workflows. The company emphasizes the importance of its digital communication with investors and encourages them to monitor updates through various channels, including its investor relations website.
Potential Positives
- Enovis Corporation is proactively engaging with investors by hosting a conference call and webcast to discuss its second quarter 2025 financial results, indicating transparency and communication with stakeholders.
- The company demonstrates a commitment to innovation in the medical technology sector, which may attract interest from investors looking for growth opportunities within the industry.
- Enovis provides multiple platforms (conference call, webcast, website) for accessing financial information, enhancing accessibility and investor engagement.
Potential Negatives
- Timing of the earnings announcement ahead of the investor conference call may suggest potential issues with Q2 financial performance or earnings expectations.
- The lack of specific financial guidance or performance metrics in the release could indicate uncertainty or volatility in the company's growth trajectory.
- The reliance on general statements about innovation and improvements without concrete examples may reduce investor confidence regarding the company's competitive position and future prospects.
FAQ
When will Enovis announce its second quarter 2025 financial results?
Enovis will announce its second quarter 2025 financial results on August 7th, 2025, at 8:30 a.m. Eastern Time.
How can investors access the Enovis conference call and webcast?
Investors can access the live webcast and conference call details through the "Investors" section of Enovis' website.
What is the contact information for Enovis Investor Relations?
The contact for Enovis Investor Relations is Kyle Rose, available at [email protected].
Is there a replay of the Enovis conference call available?
Yes, a replay of the Enovis conference call will be available on their website later that day.
What is the stock symbol for Enovis Corporation?
Enovis Corporation's shares are listed on the New York Stock Exchange under the symbol ENOV.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ENOV Hedge Fund Activity
We have seen 161 institutional investors add shares of $ENOV stock to their portfolio, and 123 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 1,502,771 shares (+26.6%) to their portfolio in Q1 2025, for an estimated $57,420,879
- DIAMOND HILL CAPITAL MANAGEMENT INC removed 918,910 shares (-32.9%) from their portfolio in Q1 2025, for an estimated $35,111,551
- HOOD RIVER CAPITAL MANAGEMENT LLC added 781,153 shares (+118.1%) to their portfolio in Q1 2025, for an estimated $29,847,856
- MAGNETAR FINANCIAL LLC removed 737,655 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $28,185,797
- VANGUARD GROUP INC added 621,069 shares (+11.3%) to their portfolio in Q1 2025, for an estimated $23,731,046
- EXODUSPOINT CAPITAL MANAGEMENT, LP added 512,476 shares (+153.8%) to their portfolio in Q1 2025, for an estimated $19,581,707
- AMERICAN CENTURY COMPANIES INC added 369,479 shares (+11.7%) to their portfolio in Q1 2025, for an estimated $14,117,792
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ENOV Analyst Ratings
Wall Street analysts have issued reports on $ENOV in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 05/14/2025
- JMP Securities issued a "Market Outperform" rating on 05/09/2025
- Needham issued a "Buy" rating on 05/09/2025
To track analyst ratings and price targets for $ENOV, check out Quiver Quantitative's $ENOV forecast page.
$ENOV Price Targets
Multiple analysts have issued price targets for $ENOV recently. We have seen 4 analysts offer price targets for $ENOV in the last 6 months, with a median target of $56.0.
Here are some recent targets:
- Vijay Kumar from Evercore ISI Group set a target price of $46.0 on 07/08/2025
- Caitlin Cronin from Canaccord Genuity set a target price of $70.0 on 05/14/2025
- David Turkaly from JMP Securities set a target price of $55.0 on 05/09/2025
- Mike Matson from Needham set a target price of $57.0 on 05/09/2025
Full Release
Wilmington, DE, July 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its second quarter 2025 financial results on Thursday, August 7th, 2025, at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call, as well as a webcast, can be accessed from the "Investors" section of Enovis' website at
www.enovis.com
.
Conference Call/Webcast Information
Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901. A replay of the call will also be available on the Enovis website later that day.
About Enovis
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com .
Availability of Information on the Enovis Website
Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis Investor Relations website. While not all of the information that the Company posts to the Enovis Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Enovis to review the information that it shares at ir.enovis.com.
Contact:
Kyle Rose
Vice President, Investor Relations
Enovis Corporation
[email protected]
